1Fran?ois Ghiringhelli,Cedric Menard,Pierre Emmanuel Puig,Sylvain Ladoire,Stephan Roux,Fran?ois Martin,Eric Solary,Axel Le Cesne,Laurence Zitvogel,Bruno Chauffert.Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients[J]. Cancer Immunology, Immunotherapy . 2007 (5) 被引量：1
3Bjoern J,Brimnes M K,Andersen M H,et al.Changes in pe-ripheral blood level of regulatory T cells in patients with malig-nant melanoma during treatment with dendritic cell vaccinationand low-dose IL-2. Scandinavian Journal of Immunology . 2011 被引量：1
4Liu J Y,Zhang X S,Ding Y,et al.The changes of CD4+CD25+/CD4+proportion in spleen of tumor-bearing BALB/cmice. Journal of Translational Medicine . 2005 被引量：1
5Shen X,Li N,Li H,et al.Increased prevalence of regulatory Tcells in the tumor microenvironment and its correlation withTNM stage of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology . 2010 被引量：1
6López M,,Aguilera R,Pérez C,et al.The role of regulatory Tlymphocytes in the induced immune response mediated by bio-logical vaccines. Immunobiology . 2006 被引量：1
7Schramm C,Huber S,Protschka M,et al.TGF beat regulatesthe CD4+CD25+T-cell pool and the expression of Foxp3 invivo. International Immunology . 2006 被引量：1
8Onodera T,Jang M H,Guo Z,et al.Constitutive expression ofIDO by dendritic cells of mesenteric lymph nodes:functionalinvolvement of the CTLA-4/B7 and CCL22/CCR4 interac-tions. J Immunol . 2009 被引量：1
9Adotevi O,Pere H,Ravel P,et al.A decrease of regulatory Tcells correlates with overall survival after sunitinib-based an-tiangiogenic therapy in metastatic renal cancer patients. JImmunother . 2010 被引量：1
10Molla Hassan A T,Hassan Z M,Moazzeni S M,et al.Nalox-one can improve the anti-tumor immunity by reducing theCD4+CD25+Foxp3+regulatory T cells in BALB/c mice. International Journal of Immunopharmacology . 2009 被引量：1
